Evidence map›Paper›PMID 37626769›Full record

ArticleBiomedicines2023

Deletion of

Omer Ophir, Gilad Levy, Ela Bar, Omri Kimchi Feldhorn, May Rokach, Galit Elad Sfadia, Boaz Barak

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Developing a minimally invasive gene therapy for multiple sclerosis.Molecular therapy. Methods & clinical development · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Omer OphirThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel.
Gilad LevyThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel.
Ela BarThe School of Psychological Sciences, Faculty of Social Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
Omri Kimchi FeldhornThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel.ORCID 0000-0002-8369-1390
May RokachThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel.
Galit Elad SfadiaThe School of Psychological Sciences, Faculty of Social Sciences, Tel Aviv University, Tel Aviv 6997801, Israel.
Boaz BarakThe Sagol School of Neuroscience, Tel Aviv University, Tel Aviv 6997801, Israel.
Tel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Williams syndrome (WS) is a neurodevelopmental disorder characterized by distinctive cognitive and personality profiles which also impacts various physiological systems. The syndrome arises from the deletion of about 25 genes located on chromosome 7q11.23, including

Indexed as

adeno-associated virus (AAV)excitatory neuronsGtf2iPHP.eB serotypepost-natal deletionsocial behaviorWilliams syndrome (WS)

Identifiers

PMID37626769
PMCPMC10452363
OpenAlexW4385834957

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.